Emulate
PrivateLast Round
Seed Round
Jun 18, 2026
Total Funding Raised
$175M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Emulate is a biotechnology company that offers an automated bio-emulation platform to accurately predict human responses to diseases, medicines, chemicals, and foods by integrating micro-engineering with living human cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emulate Comparables
Compare Emulate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CN Bio | 92% | |
| AIM Biotech | 87% | |
| AlveoliX AG | 86% | |
Emulate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 18, 2026 | ||||
| Series E | Sep 7, 2021 | ||||
| Series C | Jun 19, 2018 | ||||
| Series B Extension | Oct 20, 2016 | ||||
| Series B | Mar 28, 2016 | ||||
Series A | Jul 28, 2014 |
Emulate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SciFi Ventures | Series C |
| Perceptive Advisors | Series E |
| Founders Fund | Series C |
| +ND Capital | Series B, Series B Extension, Series A |
| ALS Investment Fund | Series C |
| OS Fund | Series B, Series B Extension |
| ATEL Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$850K Seed Round raised.
- Apr 13, 2026
Liver-Chip BioKit validated under FDA's ISTAND program.
Emulate Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Emulate's valuation, stock price, and market status.